Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study

Abstract

The study failed to achieve the primary endpoint. However, there was a potential signal from the MRI assessments suggesting givinostat could prevent (or slow down) BMD disease progression.